Marco Schiuma

1.6k total citations
16 papers, 305 citations indexed

About

Marco Schiuma is a scholar working on Infectious Diseases, Epidemiology and Neurology. According to data from OpenAlex, Marco Schiuma has authored 16 papers receiving a total of 305 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 6 papers in Epidemiology and 3 papers in Neurology. Recurrent topics in Marco Schiuma's work include Antifungal resistance and susceptibility (3 papers), COVID-19 Clinical Research Studies (3 papers) and Pneumocystis jirovecii pneumonia detection and treatment (3 papers). Marco Schiuma is often cited by papers focused on Antifungal resistance and susceptibility (3 papers), COVID-19 Clinical Research Studies (3 papers) and Pneumocystis jirovecii pneumonia detection and treatment (3 papers). Marco Schiuma collaborates with scholars based in Italy, Australia and Germany. Marco Schiuma's co-authors include Spinello Antinori, Andrea Giacomelli, Alessandro Torre, Massimo Galli, Laura Milazzo, Sara Marini, Valeria Colombo, Annalisa Ridolfo, Salvatore Parrulli and Luca Meroni and has published in prestigious journals such as Clinical Infectious Diseases, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Marco Schiuma

14 papers receiving 297 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marco Schiuma Italy 7 189 108 96 85 35 16 305
Waqar Haider Gaba United Arab Emirates 6 65 0.3× 59 0.5× 92 1.0× 98 1.2× 28 0.8× 15 242
Mahtab Uddin Hassan Thailand 6 40 0.2× 32 0.3× 80 0.8× 21 0.2× 28 0.8× 10 262
Sunny Chi Lik Au China 8 111 0.6× 111 1.0× 20 0.2× 13 0.2× 30 0.9× 62 240
Heshmatollah Ghanbari Iran 11 355 1.9× 245 2.3× 85 0.9× 10 0.1× 36 1.0× 42 429
Rozita Khodashahi Iran 5 49 0.3× 12 0.1× 43 0.4× 53 0.6× 26 0.7× 40 164
Beom Soo Kim United States 3 33 0.2× 12 0.1× 64 0.7× 168 2.0× 31 0.9× 9 274
Rakesh D. Mistry United States 9 16 0.1× 18 0.2× 50 0.5× 54 0.6× 12 0.3× 19 199
Ahmed Ghazy Egypt 5 7 0.0× 71 0.7× 54 0.6× 122 1.4× 23 0.7× 13 250
Marios Constantinou Australia 13 344 1.8× 224 2.1× 3 0.0× 25 0.3× 29 0.8× 21 450
Vanita Arora India 6 12 0.1× 14 0.1× 56 0.6× 38 0.4× 8 0.2× 21 341

Countries citing papers authored by Marco Schiuma

Since Specialization
Citations

This map shows the geographic impact of Marco Schiuma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Schiuma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Schiuma more than expected).

Fields of papers citing papers by Marco Schiuma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Schiuma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Schiuma. The network helps show where Marco Schiuma may publish in the future.

Co-authorship network of co-authors of Marco Schiuma

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Schiuma. A scholar is included among the top collaborators of Marco Schiuma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Schiuma. Marco Schiuma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Gervasoni, Cristina, Giacomo Casalini, Alessandro Torre, et al.. (2025). An outbreak of acute pulmonary histoplasmosis after exposure to guano in a hollow tree in Ecuador. Travel Medicine and Infectious Disease. 67. 102902–102902.
2.
Schiuma, Marco, Marta Colaneri, Dario Cattaneo, et al.. (2025). Rifampicin drug monitoring in TB patients: new evidence for increased dosage?. The International Journal of Tuberculosis and Lung Disease. 29(5). 202–206.
3.
Schiuma, Marco, Vera Battini, Alessandro Torre, et al.. (2025). NAT2 Acetylation Status Predicts Hepatotoxicity During Antituberculosis Therapy: Cumulative Risk Analysis of a Multiethnic Cohort. International Journal of Molecular Sciences. 26(8). 3881–3881. 1 indexed citations
4.
Cheli, Stefania, Alessandro Torre, Marco Schiuma, et al.. (2024). NAT2 Slow Acetylator Phenotype as a Significant Risk Factor for Hepatotoxicity Caused by Antituberculosis Drugs: Results From a Multiethnic Nested Case-Control Study. Clinical Infectious Diseases. 81(1). 145–152. 1 indexed citations
5.
Cattaneo, Dario, Alessandro Torre, Marco Schiuma, et al.. (2024). Management of Polypharmacy and Potential Drug–Drug Interactions in Patients with Pulmonary Aspergillosis: A 2-Year Study of a Multidisciplinary Outpatient Clinic. Journal of Fungi. 10(2). 107–107. 2 indexed citations
6.
Cattaneo, Dario, Alessandro Torre, Marco Schiuma, et al.. (2023). Management of Polypharmacy and Potential Drug–Drug Interactions in Patients with Mycobacterial Infection: A 1-Year Experience of a Multidisciplinary Outpatient Clinic. Antibiotics. 12(7). 1171–1171. 2 indexed citations
7.
Birindelli, Sarah, Maciej Tarkowski, Marcello Gallucci, et al.. (2022). Definition of the Immune Parameters Related to COVID-19 Severity. Frontiers in Immunology. 13. 850846–850846. 6 indexed citations
8.
Gidaro, Antonio, Francesco Casella, Chiara Cogliati, et al.. (2022). Midline peripheral catheters inserted in the superficial femoral vein at mid-thigh: Wise choice in COVID-19 acute hypoxemic respiratory failure patients with helmet continuous positive airway pressure. The Journal of Vascular Access. 24(6). 1469–1476. 8 indexed citations
9.
Tarkowski, Maciej, Wilco de Jager, Marco Schiuma, et al.. (2021). Anti-SARS-CoV-2 Immunoglobulin Isotypes, and Neutralization Activity Against Viral Variants, According to BNT162b2-Vaccination and Infection History. Frontiers in Immunology. 12. 793191–793191. 14 indexed citations
10.
Invernizzi, Alessandro, Marco Schiuma, Salvatore Parrulli, et al.. (2021). Retinal vessels modifications in acute and post-COVID-19. Scientific Reports. 11(1). 19373–19373. 28 indexed citations
11.
Antinori, Spinello, Andrea Giacomelli, Mario Corbellino, et al.. (2021). Histoplasmosis Diagnosed in Europe and Israel: A Case Report and Systematic Review of the Literature from 2005 to 2020. Journal of Fungi. 7(6). 481–481. 27 indexed citations
12.
13.
Schiuma, Marco, Laura Pezzati, Elisabetta Ballone, et al.. (2021). Case Report: A Fatal Case of West Nile Virus Meningoencephalomyelitis in a Woman with Systemic Lupus Erythematosus Initially Misdiagnosed as SARS-CoV-2 Infection. American Journal of Tropical Medicine and Hygiene. 104(5). 1716–1718. 3 indexed citations
14.
Invernizzi, Alessandro, Alessandro Torre, Salvatore Parrulli, et al.. (2020). Retinal findings in patients with COVID-19: Results from the SERPICO-19 study. EClinicalMedicine. 27. 100550–100550. 186 indexed citations
15.
Cattaneo, Dario, Luca Pasina, Aldo P. Maggioni, et al.. (2020). Drug–Drug Interactions and Prescription Appropriateness in Patients with COVID-19: A Retrospective Analysis from a Reference Hospital in Northern Italy. Drugs & Aging. 37(12). 925–933. 20 indexed citations
16.
Cattaneo, Dario, Luca Pasina, Aldo P. Maggioni, et al.. (2020). Drug-Drug Interactions and Prescription Appropriateness in COVID-19 Patients: A Retrospective Analysis from a Reference Hospital in Northern Italy. SSRN Electronic Journal. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026